Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Marie‐Claire Devilder"'
Autor:
Romane Durand, Céline Bellanger, Géraldine Descamps, Christelle Dousset, Sophie Maïga, Jennifer Derrien, Laura Thirouard, Louise Bouard, Hélène Asnagli, Philip Beer, Andrew Parker, Patricia Gomez‐Bougie, Marie‐Claire Devilder, Philippe Moreau, Cyrille Touzeau, Agnès Moreau‐Aubry, David Chiron, Catherine Pellat‐Deceunynck
Publikováno v:
HemaSphere, Vol 8, Iss 10, Pp n/a-n/a (2024)
Abstract In multiple myeloma, as in B‐cell malignancies, mono‐ and especially bi‐allelic TP53 gene inactivation is a high‐risk factor for treatment resistance, and there are currently no therapies specifically targeting p53 deficiency. In thi
Externí odkaz:
https://doaj.org/article/13eb39e4b90348b0a8b866dcf7917e42
Autor:
Marie-Claire Devilder, Melinda Moyon, Laetitia Gautreau-Rolland, Benjamin Navet, Jeanne Perroteau, Florent Delbos, Marie-Claude Gesnel, Richard Breathnach, Xavier Saulquin
Publikováno v:
BMC Biotechnology, Vol 19, Iss 1, Pp 1-13 (2019)
Externí odkaz:
https://doaj.org/article/95a8770de07242eb82ca1694c5713257
Autor:
Nolwenn Legrand, Perla Salameh, Maxime Jullien, Patrice Chevallier, Enora Ferron, Gaelle David, Marie-Claire Devilder, Catherine Willem, Ketevan Gendzekhadze, Peter Parham, Christelle Retière, Katia Gagne
Publikováno v:
Cancers; Volume 15; Issue 10; Pages: 2754
KIR3DL1 alleles are expressed at different levels on the natural killer (NK) cell surface. In particular, the non-expressed KIR3DL1*004 allele appears to be common in Caucasian populations. However, the overall distribution of non-expressed KIR3DL1 a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11c97f14038cd27ce4dde0224a8f6d95
https://doi.org/10.3390/cancers15102754
https://doi.org/10.3390/cancers15102754
Autor:
Ngoc-Khanh Nguyen, Marie-Claire Devilder, Laetitia Gautreau-Rolland, Cynthia Fourgeux, Debajyoti Sinha, Jeremie Poschmann, Maryvonne Hourmant, Céline Bressollette-Bodin, Xavier Saulquin, Dorian McIlroy
Publikováno v:
Life Science Alliance. 6:e202201567
The BK polyomavirus (BKPyV) is an opportunistic pathogen, which is only pathogenic in immunosuppressed individuals, such as kidney transplant recipients, in whom BKPyV can cause significant morbidity. To identify broadly neutralizing antibodies again
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::625198cfea4c344ef50f56ac1c73c25a
https://doi.org/10.26508/lsa.202201567
https://doi.org/10.26508/lsa.202201567
Autor:
Xavier Saulquin, Marie-Claire Devilder, Laurent Gapin, Benjamin Navet, Emmanuel Scotet, Laetitia Gautreau-Rolland, Leslie Hesnard, Jeanne Perroteau
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e068a35ec4902a661df59f449b1ad77
https://doi.org/10.1002/eji.201948416/v2/response1
https://doi.org/10.1002/eji.201948416/v2/response1
Autor:
Laurent Gapin, Marie-Claire Devilder, Xavier Saulquin, Laetitia Gautreau-Rolland, Leslie Hesnard, Jeanne Perroteau, Benjamin Navet, Emmanuel Scotet
Publikováno v:
European Journal of Immunology
European Journal of Immunology, Wiley-VCH Verlag, 2020, Online ahead of print. ⟨10.1002/eji.201948416⟩
European Journal of Immunology, 2020, Online ahead of print. ⟨10.1002/eji.201948416⟩
European Journal of Immunology, Wiley-VCH Verlag, 2020, Online ahead of print. ⟨10.1002/eji.201948416⟩
European Journal of Immunology, 2020, Online ahead of print. ⟨10.1002/eji.201948416⟩
International audience; Invariant Natural Killer T (iNKT) cells are particular T lymphocytes at the frontier between innate and adaptative immunities. They participate in the elimination of pathogens or tumor cells, but also in the development of all
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::997569327c2e82c4a370de80c031de90
https://pubmed.ncbi.nlm.nih.gov/32460359
https://pubmed.ncbi.nlm.nih.gov/32460359
Autor:
Marie-Claire Devilder, Moyon, Melinda, Gautreau-Rolland, Laetitia, Navet, Benjamin, Perroteau, Jeanne, Delbos, Florent, Marie-Claude Gesnel, Breathnach, Richard, Saulquin, Xavier
Table S1. Isolation of human anti-HLA-A2 B lymphocytes from the PBMC of grafted patients.This table indicates the number of HLA-A2-specific B cells isolated from each donors.Table S2. Full nucleotide sequences.This table indicates the nucleotide sequ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee7d62db3045bc9d8db0959f4296aee9
Publikováno v:
Journal of visualized experiments : JoVE
Journal of visualized experiments : JoVE, JoVE, 2018, pp.e56508. ⟨10.3791/56508⟩
Journal of visualized experiments : JoVE, 2018, 132, pp.e56508. ⟨10.3791/56508⟩
Journal of visualized experiments : JoVE, JoVE, 2018, pp.e56508. ⟨10.3791/56508⟩
Journal of visualized experiments : JoVE, 2018, 132, pp.e56508. ⟨10.3791/56508⟩
International audience; Monoclonal antibodies (mAbs) are powerful tools useful for both fundamental research and in biomedicine. Their high specificity is indispensable when the antibody needs to distinguish between highly related structures (e.g., a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3509468bee8b82648bd4f5a15163aff1
https://www.hal.inserm.fr/inserm-01745629
https://www.hal.inserm.fr/inserm-01745629
Autor:
Laetitia Gautreau-Rolland, Melinda Moyon, Laure-Hélène Ouisse, Xavier Saulquin, Jonathan Visentin, Frank Halary, Marie-Claire Devilder, Roland Buelow, Marianne Brüggemann, Ignacio Anegon, Michael J. Osborn
Publikováno v:
BMC Biotechnology
BMC Biotechnology, BioMed Central, 2017, 17 (1), pp.3. ⟨10.1186/s12896-016-0322-5⟩
BMC Biotechnology, 2017, 17 (1), pp.3. ⟨10.1186/s12896-016-0322-5⟩
BMC Biotechnology, BioMed Central, 2017, 17 (1), pp.3. ⟨10.1186/s12896-016-0322-5⟩
BMC Biotechnology, 2017, 17 (1), pp.3. ⟨10.1186/s12896-016-0322-5⟩
Background There is an ever-increasing need of monoclonal antibodies (mAbs) for biomedical applications and fully human binders are particularly desirable due to their reduced immunogenicity in patients. We have applied a strategy for the isolation o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47bd814fb3808646807a5ac6bba7c47c
https://www.hal.inserm.fr/inserm-01444749/document
https://www.hal.inserm.fr/inserm-01444749/document
Autor:
François Legoux, Alexandra Leger, Laetitia Gautreau, Melinda Moyon, Xavier Saulquin, Leslie Hesnard, Marc Bonneville, Marie-Claire Devilder
Publikováno v:
European Journal of Immunology. 43:3244-3253
While CD4+ T lymphocytes usually recognize antigens in the context of major histocompatibility (MHC) class II alleles, occurrence of MHC class-I restricted CD4+ T cells has been reported sporadically. Taking advantage of a highly sensitive MHC tetram
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c670de47036e807cacc82b15a4f8a789
https://doi.org/10.1002/eji.201343726
https://doi.org/10.1002/eji.201343726